KLIVEMTO Trademark

Trademark Overview

On Friday, May 30, 2008, a trademark application was filed for KLIVEMTO with the United States Patent and Trademark Office. The USPTO has given the KLIVEMTO trademark a serial number of 77486891. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, April 13, 2011. This trademark is owned by AstraZeneca AB. The KLIVEMTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
klivemto

General Information

Serial Number77486891
Word MarkKLIVEMTO
Filing DateFriday, May 30, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, April 13, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
Translation of Words in MarkThe mark has no translation, meaning or significance in the industry in which the goods will be manufactured.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 3, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje
SE

Trademark Events

Event DateEvent Description
Wednesday, April 13, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, April 13, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 13, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, September 13, 2010INQUIRY TO SUSPENSION E-MAILED
Monday, September 13, 2010SUSPENSION INQUIRY WRITTEN
Thursday, March 11, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 11, 2010LETTER OF SUSPENSION E-MAILED
Thursday, March 11, 2010SUSPENSION LETTER WRITTEN
Thursday, March 11, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 11, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 10, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, September 11, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, September 11, 2009INQUIRY TO SUSPENSION E-MAILED
Friday, September 11, 2009SUSPENSION INQUIRY WRITTEN
Friday, September 11, 2009ASSIGNED TO EXAMINER
Wednesday, August 26, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, February 20, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 20, 2009LETTER OF SUSPENSION E-MAILED
Friday, February 20, 2009SUSPENSION LETTER WRITTEN
Thursday, February 19, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, February 19, 2009ASSIGNED TO LIE
Thursday, February 19, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 19, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, February 19, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, September 11, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 11, 2008NON-FINAL ACTION E-MAILED
Thursday, September 11, 2008NON-FINAL ACTION WRITTEN
Wednesday, September 10, 2008ASSIGNED TO EXAMINER
Tuesday, June 3, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

klivemto pharmaceutical treatment preparations disorders diseases diabetes cancer neurological infection psychiatric